Classification of relapses in 64 case subjects by ALL-BFM trial
| . | No. of Subjects and Prevalence (%) . | |
|---|---|---|
| ALL-BFM 86 (n = 35) . | ALL-BFM 90 (n = 29) . | |
| Time to relapse (y) | ||
| <2 | 7 (20.0) | 6 (20.7) |
| 2-5 | 25 (71.4) | 19 (65.5) |
| >5 | 3 (8.6) | 4 (13.8) |
| Type of relapse | ||
| Isolated relapse | ||
| Bone marrow | 19 (54.3) | 16 (55.2) |
| CNS | 3 (8.6) | — |
| Testis | 3 (8.6) | 2 (6.9) |
| Other | — | 1 (3.4) |
| Combined relapse | ||
| Bone marrow/CNS | 5 (14.3) | 7 (24.1) |
| Bone marrow/testis | 4 (11.4) | 2 (6.9) |
| Bone marrow/CNS/testis | 1 (2.9) | — |
| Other | — | 1 (3.4) |
| . | No. of Subjects and Prevalence (%) . | |
|---|---|---|
| ALL-BFM 86 (n = 35) . | ALL-BFM 90 (n = 29) . | |
| Time to relapse (y) | ||
| <2 | 7 (20.0) | 6 (20.7) |
| 2-5 | 25 (71.4) | 19 (65.5) |
| >5 | 3 (8.6) | 4 (13.8) |
| Type of relapse | ||
| Isolated relapse | ||
| Bone marrow | 19 (54.3) | 16 (55.2) |
| CNS | 3 (8.6) | — |
| Testis | 3 (8.6) | 2 (6.9) |
| Other | — | 1 (3.4) |
| Combined relapse | ||
| Bone marrow/CNS | 5 (14.3) | 7 (24.1) |
| Bone marrow/testis | 4 (11.4) | 2 (6.9) |
| Bone marrow/CNS/testis | 1 (2.9) | — |
| Other | — | 1 (3.4) |
CNS: central nervous system.